Replies to post #164370 on Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

DesireToLearn, I agree.

The anti-inflammatory properties seen in ulcerative proctitis support our optimism in the Phase 2 trial of Brilacidin-OM for head and neck cancer patients, suffering from oral mucositis.

By definition, oral mucositis is an inflammatory condition. Having data, demonstrating Brilacidin can fight inflammation and doesn't accumulate in the blood is a major benefit for what can be a painful and expensive condition that doesn't have any FDA approved treatments. We greatly look forward to additional data from this trial expected in the first half of 2017.

http://seekingalpha.com/article/4023682-cellceutix-corporation-ctix-ceo-leo-ehrlich-q1-2017-results-earnings-call-transcript?part=single

Good luck and GOD bless,

George